Letter Regarding “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”

We read with interest the recent publication by Khan et al. [1] in Clinical Cardiology titled “Outcomes of Bolus Dose Furosemide Versus Continuous Infusion in Patients With Acute Decompensated Left Ventricular Failure and Atrial Fibrillation”. While the article provides valuable insights into different furosemide strategies in managing patients with acute decompensated heart failure, we noticed an error in Table 1, which presents the baseline patient characteristics. Specifically, the reported patient population underwent a sudden and significant reduction in the arms of the study; for example, an initial cohort of 479 patients reduced or reported to only 14 patients in the T1 arm (intravenous bolus infusion in the table). This error has the potential to misinterpret the results and conclusions of the study.

We believe these clarifications are essential for readers to fully comprehend the validity and applicability of the study's findings.

We kindly request the authors and the journal to rectify this error promptly. A corrected version of Table 1 should be published to ensure accurate interpretation of the study findings.

The authors declare no conflicts of interest.